Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cambridge Nutraceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Cambridge Nutraceuticals

Cambridge Nutraceuticals

Seed

Cambridge Nutraceuticals, a supplement company, develops bioavailable, clinically-proven products, supported by a high-profile medical board.

Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded in 2012 and based in central Cambridge, Cambridge Nutraceuticals focuses on developing bioavailable supplements with clinically proven benefits. Initially launching with "Ateronon," a patented form of bioavailable lycopene, the company expanded its product line in December 2015 under the brand FutureYou. Their mission is to enhance health through scientifically-backed supplements, leveraging close ties with Cambridge University to ensure rigorous research and development.

Cambridge Nutraceuticals boasts a high-profile medical board that supports its scientific endeavors. Notable achievements include the successful market introduction of multiple clinically-proven supplements and significant growth since its inception. The company's impact lies in its commitment to evidence-based health solutions, contributing to the broader nutraceutical market with products that prioritize efficacy and bioavailability.

Cambridge Nutraceuticals - Similar Companies

Cambridge Nutraceuticals logo

Cambridge Nutraceuticals

camnutra.com

BodyBio logo

BodyBio

bodybio.co.uk

Brainceuticals logo

Brainceuticals

brainceuticals.com

Columbia Nutritional logo

Columbia Nutritional

Sevo Nutraceuticals logo

Sevo Nutraceuticals

Nutranomics logo

Nutranomics

Athletic Greens logo

Athletic Greens

athleticgreens.com

Salvation Nutraceuticals logo

Salvation Nutraceuticals

trygshplus.com

Nutrigene logo

Nutrigene

Cognutria Foods logo

Cognutria Foods

Platinum Biosciences logo

Platinum Biosciences

NutraLife Biosciences logo

NutraLife Biosciences

Pure Encapsulations logo

Pure Encapsulations

Nutrafol logo

Nutrafol

nutrafol.com

NeuroReserve logo

NeuroReserve

neuroreserve.com

Cambridge Nutraceuticals - Quick Facts

Who are Cambridge Nutraceuticals' competitors?

Companies similar to Cambridge Nutraceuticals include Cambridge Nutraceuticals, BodyBio, Brainceuticals and Columbia Nutritional.

When was Cambridge Nutraceuticals founded?

Cambridge Nutraceuticals was founded in 2010.

When was Cambridge Nutraceuticals' last funding round?

Cambridge Nutraceuticals' most recent funding round was for $1.9M (USD) in January 2018.

How much has Cambridge Nutraceuticals raised to-date?

As of Jan 1, 2018, Cambridge Nutraceuticals has raised a total of $2.9M (USD).

How many employees does Cambridge Nutraceuticals have?

Cambridge Nutraceuticals has 1 employee as of Mar 1, 2024.

Cambridge Nutraceuticals - Classification

Industry
  • Retail
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Supplements
Tags
  • eCommerce
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
Show 2 more industry codes
SIC
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified